T Rowe PR Health Science-InvPRHSX
13F holders, Q1 2026 (March 31)2holders −2
0new positions
2sold out
$78.86avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, down 2 from Q4 2025. 0 opened new positions and 2 sold out. The largest holders were Westside Investment Management, Inc. ($116K) and Financial Gravity Asset Management, Inc. ($10K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $270K |
All 13F filers, Q4 2025 → Q1 2026: 3,228 shares sold, net −3,228 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Westside Investment Management, Inc. | 0.02% | No change | 1,467 | $116K |
| Financial Gravity Asset Management, Inc. | 0.00% | No change | 122 | $10K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.